David Livermore - eucast

More documents

Recommendations

Info

ChromID ESBL (bioMerieux)• Selective agar withmultiple antibioticsincluding cefpodoximeE. coli pink –K. pneumoniae greenP. mirabilis brown• Rapid detection ofcommon ESBL+enterobacteria within18-24h of specimen
Chromogenic media to detectESBL producers- 765 specimensChromID ESBL(bioMerieux)True+False+False-SensitivityPPV29 46 4 88% 38%BLSE (AES)* 28 154 5 85% 15%ChromID : proprietary, cefpodoxime basedBLSE : 2 compartments : Drigalski agar + cefotaxime, 1.5 mg/LMacConkey + 2 mg/L ceftazidimeReglier-Poupet et al. JMM 2008; 57, 310
Page 1 and 2: -Lactam susceptibility testsAcademi
Page 3: Mortality in ESBL vs. non-ESBLEnter
Page 6 and 7: Outcome & MIC in bacteraemias withC
Page 9 and 10: Ceftazidime MICs for Enterobacteria
Page 11 and 12: E. coli NCTC13352. K-12 derivativew
Page 13 and 14: NCTC13352: Unedited results forcefo
Page 15 and 16: Third (& Say it in whispers…)For
Page 17: Delay in appropriate R x ESBL vs.no
Page 22 and 23: Cica b-Test (Mast) blind testingof
Page 24 and 25: Carbapenem R x in infectionswith KP
Page 26 and 27: Fourth point: only by beingalert do
Page 28: Report by mechanism• Ceph MICs of

David Livermore - eucast

Create successful ePaper yourself

Delete template?

Save as template?